Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Downgrades Oramed Pharmaceuticals to Neutral

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) from Buy to Neutral.

byBenzinga Newsdesk

January 17, 2023

1 minute read

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) from Buy to Neutral.

FDA
News

‘First probable case of Monkeypox identified in New Hampshire’ -Local NBC Outlet

By Benzinga Newsdesk

Today, 3:24 AM

https://www.mynbc5.com/article/first-case-monkeypox-in-new-hampshire/40462421?utm_campaign=snd-autopilot

AEMD

Lixte Biotechnology’s LB-100 Reported To Convert Immunologically Unresponsive Tumors To Immunologically Responsive Tumors

By Benzinga Newsdesk

Today, 3:24 AM

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer treatment, announced today that in preclinical studies its

LIXT

Southwest Airlines Sees Q3 Operating Revenue Up 9-11% Compared With 2019; Co. Experienced Strong Travel Demand For Labor Day Holiday And Continues To Experience Strong Revenue Trends In Q3 2022

By Benzinga Newsdesk

Today, 3:24 AM

https://www.sec.gov/ix?doc=/Archives/edgar/data/92380/000009238022000053/luv-20220915.htm

LUV

Morgan Stanley Maintains Equal-Weight on 8×8, Lowers Price Target to $4

By Benzinga Newsdesk

Today, 3:24 AM

Morgan Stanley analyst Meta Marshall maintains 8x8 (NYSE:EGHT) with a Equal-Weight and lowers the price target from $6.5 to $4.

EGHT

HC Wainwright & Co. Downgrades Oramed Pharmaceuticals to Neutral

Related Posts

‘First probable case of Monkeypox identified in New Hampshire’ -Local NBC Outlet

Lixte Biotechnology’s LB-100 Reported To Convert Immunologically Unresponsive Tumors To Immunologically Responsive Tumors

Southwest Airlines Sees Q3 Operating Revenue Up 9-11% Compared With 2019; Co. Experienced Strong Travel Demand For Labor Day Holiday And Continues To Experience Strong Revenue Trends In Q3 2022

Morgan Stanley Maintains Equal-Weight on 8×8, Lowers Price Target to $4